Haemophilia A
Haemophilia A is a rare genetic disorder where the blood does not clot properly due to a deficiency of clotting factor VIII, leading to excessive bleeding and bruising.
We are studying how well Nuwiq works to control bleeding during major surgery for women and girls with hemophilia A. The trial will also look at its safety and effects on blood product use.
Health conditions and diseases that the clinical trial is designed to study and treat.
Haemophilia A is a rare genetic disorder where the blood does not clot properly due to a deficiency of clotting factor VIII, leading to excessive bleeding and bruising.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.